May 25, 2022 01:02 PM EDTUpdated 05:18 PM
Pharma
Law

New law­suit ac­cus­es GSK of 'de­vice hop­ping' to block gener­ic in­haler com­pe­ti­tion

Nicole DeFeudis

Editor

De­spite in­halers be­ing on the mar­ket for decades, many pa­tients still can’t af­ford them. A new law­suit filed in Mis­souri fed­er­al court puts the blame …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Ver­tex's bid to of­fer Cas­gevy fer­til­i­ty sup­port is 'self-serv­ing,' HHS says

#JPM25 live blog day 3: PhRMA chief on re­form­ing the IRA; Gilead weighs in on Chi­na deal­mak­ing

Drug­mak­ers tout lim­its of IRA im­pact ahead of next ne­go­ti­a­tion round

FDA ex­plains why it re­ject­ed Van­da's stom­ach drug in late 2024

On­col­o­gy biotech plots ex­pe­dit­ed ap­proval for bone can­cer drug af­ter Phase 2 win

BIO CEO plans to join FDA mod­ern­iza­tion ad­vi­so­ry board un­der Trump ad­min­is­tra­tion

A service from the Financial Times